Venous Thromboembolism in Children

Pediatric Clinics of North America

Volumn 55, Issue 2, 2008, Pages 305-322

  Goldenberg, Neil A ^a,b   Bernard, Timothy J ^a,b  

^a Mountain States Regional Hemophilia and Thrombosis Center   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBIN; ARGATROBAN; ASPARAGINASE; BLOOD CLOTTING FACTOR 10A INHIBITOR; DALTEPARIN; DEFIBROTIDE; ENOXAPARIN; ESTROGEN; HEPARIN; LEPIRUDIN; LOW MOLECULAR WEIGHT HEPARIN; ORAL CONTRACEPTIVE AGENT; THROMBIN INHIBITOR; WARFARIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; AWARENESS; CLINICAL FEATURE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONGENITAL MALFORMATION; DEEP VEIN THROMBOSIS; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; DOPPLER ECHOCARDIOGRAPHY; DRUG EFFICACY; DRUG ELIMINATION; DRUG FORMULATION; DRUG HALF LIFE; GENETIC DISORDER; HUMAN; INCIDENCE; LABORATORY TEST; MEDICAL EDUCATION; MEDICAL INSTRUMENTATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PHLEBOGRAPHY; PROGNOSIS; PROPHYLAXIS; REVIEW; SKIN NECROSIS; SURVIVAL; THROMBOCYTOPENIA; THROMBOPHILIA; TREATMENT OUTCOME; VEIN OCCLUSION; VENOUS THROMBOEMBOLISM;

ANTICOAGULANTS; CHILD; DIAGNOSTIC IMAGING; HUMANS; PROGNOSIS; THROMBOEMBOLISM; THROMBOLYTIC THERAPY; VENOUS THROMBOSIS;

EID: 41149101175     PISSN: 00313955     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pcl.2008.01.003     Document Type: Review

References (63)

1. Andrew M., David M., Adams M., et al. Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE. Blood 83 (1994) 1251-1257
2. van Ommen C.H., Heijboer H., Buller H.R., et al. Venous thromboembolism in childhood: a prospective two-year registry in the Netherlands. J Pediatr 139 (2001) 676-681
3. Stein P.D., Kayali R., Olson R.E., et al. Incidence of venous thromboembolism in infants and children: data from the National Hospital Discharge Survey. J Pediatr 145 (2004) 563-565
4. Monagle P., Adams M., Mahoney M., et al. Outcome of pediatric thromboembolic disease: a report from the Canadian Childhood Thrombophilia Registry. Pediatr Res 47 (2000) 763-766
5. Goldenberg N.A., Knapp-Clevenger R., Manco-Johnson M.J., et al. Elevated plasma factor VIII and D-dimer levels as predictors of poor outcomes of thrombosis in children. N Engl J Med 351 (2004) 1081-1088
6. Schmidt B., and Andrew M. Neonatal thrombosis: report of a prospective Canadian and international registry. Pediatrics 96 (1995) 939-943
7. David M., and Andrew M. Venous thromboembolic complications in children. J Pediatr 123 (1993) 337-346
8. Buck J.R., Connor R.H., Cook W.W., et al. Pulmonary embolism in children. J Pediatr Surg 16 (1981) 385-391
9. Van Ommen C.H., and Peters M. Acute pulmonary embolism in childhood. Thromb Res 118 1 (2006) 13-25
10. Hoyer P.F., Gonda S., Barthels M., et al. Thromboembolic complications in children with nephritic syndrome. Risk and incidence. Acta Paediatr Scand 75 (1986) 804-810
11. Lewy P.R., and Jao W. Nephrotic syndrome in association with renal vein thrombosis in infancy. J Pediatr 85 (1974) 359-365
12. Goldenberg N.A., Knapp-Clevenger R., Hays T., et al. Lemierre's and Lemierre's-like syndromes in children: survival and thromboembolic outcomes. Pediatrics 116 (2005) e543-e548
13. Manco-Johnson M.J., Grabowski E.F., Hellgreen M., et al. Laboratory testing for thrombophilia in pediatric patients. On behalf of the Subcommittee for Perinatal and Pediatric Thrombosis of the Scientific and Standardization Committee of the International Society on Threombosis and Haemostasis (ISTH). Thromb Haemost 88 (2002) 155-156
14. Monagle P., Chan A., Massicotte P., et al. Antithrombotic therapy in children: the Seventh ACCP Conference on Antithrombotic and Thrombotic Therapy. Chest 126 Suppl 3 (2004) 645S-687S
15. Manco-Johnson M. How I treat venous thrombosis in children. Blood 107 (2006) 21-29
16. Nohe N., Flemmer A., Rumler R., et al. The low molecular weight heparin dalteparin for prophylaxis and therapy of thrombosis in childhood: a report on 48 cases. Eur J Pediatr 158 (1999) S134-S139
17. Andrew M., Marzinotto V., Massicotte P., et al. Heparin therapy in pediatric patients: a prospective cohort study. Pediatr Res 35 (1994) 78-83
18. Hull R.D., Raskob G.E., Rosenbloom D., et al. Heparin for 5 days as compared with 10 days in the initial treatment of proximal venous thrombosis. N Engl J Med 322 (1990) 1260-1264
19. Kearon C., Ginsberg J.S., Julina J.A., et al. Comparison of fixed-dose weight-adjusted unfractionated heparin and low-molecular-weight heparin for acute treatment of venous thromboembolism. JAMA 296 (2006) 935-942
20. Berube C., Mitchell L., Silverman E., et al. The relationship of antiphospholipid antibodies to thromboembolic events in pediatric patients with systemic lupus erythematosus: a cross-sectional study. Pediatr Res 44 (1998) 351-356
21. Monagle P., and Andew M. Acquired disorders of hemostasis. In: Nathan D.G., Stuart H., and Orkin A. (Eds). Nathan and Oski's hematology of infancy and childhood. 6th edition (2003), Saunders, Philadelpia
22. Kearon C., Ginsberg J.S., Kovacs M.J., et al. Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism. N Engl J Med 349 (2003) 631-639
23. Kovacs M.J. Long-term low-dose warfarin use is effective in the prevention of recurrent venous thromboembolism: no. J Thromb Haemost 2 (2004) 1041-1043
24. Goldenberg N.A., Knapp-Clevenger R., Durham J.D., et al. A thrombolytic regimen for high-risk deep venous thrombosis may substantially reduce the risk of post-thrombotic syndrome in children. Blood 110 (2007) 45-53
25. Vukovich T., Auberger K., Weil J., et al. Replacement therapy for a homozygous protein C deficiency state using a concentrate of human protein C and S. Br J Haematol 70 (1988) 435-440
26. Dreyfus M., Masterson M., David M., et al. Replacement therapy with a monoclonal antibody purified protein C concentrate in newborns with severe congenital protein C deficiency. Semin Thromb Hemost 21 (1995) 371-381
27. Dreyfus M., Magny J.F., Bridey F., et al. Treatment of homozygous protein C deficiency and neonatal purpura fulminans with a purified protein C concentrate. N Engl J Med 325 (1991) 1565-1568
28. Muller F.M., Ehrenthal W., Hafner G., et al. Purpura fulminans in severe congenital protein C deficiency: monitoring of treatment with protein C concentrate. Eur J Pediatr 155 (1996) 20-25
29. de Kleijn E.D., de Groot R., Hack C.E., et al. Activation of protein C following infusion of protein C concentrate in children with severe meningococcal sepsis and purpura fulminans: a randomized, double-blinded, placebo-controlled, dose-finding study. Crit Care Med 31 (2003) 1839-1847
30. Ettingshausen C.E., Veldmann A., Beeg T., et al. Replacement therapy with protein C concentrate in infants and adolescents with meningococcal sepsis and purpura fulminans. Semin Thromb Hemost 25 (1999) 537-541
31. Rivard G.E., David M., Farrell C., et al. Treatment of purpura fulminans in meningococcemia with protein C concentrate. J Pediatr 126 4 (1995) 646-652
32. Konkle B.A., Bauer K.A., Weinstein R., et al. Use of recombinant human antithrombin in patients with congenital antithrombin deficiency undergoing surgical procedures. Transfusion 43 (2003) 390-394
33. Zaunschirm A., and Muntean W. Correction of hemostatic imbalances induced by L-asparaginase therapy in children with acute lymphoblastic leukemia. Pediatr Hematol Oncol 3 (1986) 19-25
34. Mitchell L., Andrew M., Hanna K., et al. Trend to efficacy and safety using antithrombin concentrate in prevention of thrombosis in children receiving L-asparaginase for acute lymphoblastic leukemia. Results of the PARKAA study. Thromb Haemost 90 (2003) 235-244
35. Haussmann U., Fischer J., Eber S., et al. Hepatic veno-occlusive disease in pediatric stem cell transplantation: impact of pre-emptive antithrombin III replacement and combin antithrombin III/defibrotide therapy. Haematologica 91 (2006) 795-800
36. Meister B., Kropshofer G., Klein-Franke A., et al. Comparison of low-molecular-weight heparin and antithrombin versus antithrombin alone for the prevention of thrombosis in children with acute lymphoblastic leukemia. Pediatr Blood Cancer 50 2 (2008) 298-303
37. Cahn M.D., Rohrer M.J., Martella M.B., et al. Long-term follow-up of Greenfield inferior vena cava filter placement in children. J Vasc Surg 34 (2001) 820-825
38. Goldenberg N.A. Long-term outcomes of venous thrombosis in children. Curr Opin Hematol 12 (2005) 370-376
39. van Ommen C.H., Heijboer H., van den Dool E.J., et al. Pediatric venous thromboembolic disease in one single center: congenital prothrombotic disorders and the clinical outcome. J Thromb Haemost 1 (2003) 2516-2522
40. Bick R.L. Prothrombin G20210A mutation, antithombin, heparin cofactor II, protein C, and protein S defects. Hematol Oncol Clin North Am 17 (2003) 9-36
41. Prandoni P., Lensing A.W., Cogo A., et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med 125 (1996) 1-7
42. Nowak-Göttl U., Junker R., Kruez W., et al. Risk of recurrent venous thrombosis in children with combined prothrombotic risk factors. Blood 97 (2001) 858-862
43. Massicotte P., Julian J.A., Gent M., et al. An open label randomized controlled trial of low molecular weight heparin compared to heparin and Coumadin for the treatment of venous thromboembolic events in children: the REVIVE trial. Thromb Res 109 (2003) 85-92
44. Oren H., Devecioglu O., Ertem M., et al. Analysis of pediatric thrombotic patients in Turkey. Pediatr Hematol Oncol 21 (2004) 573-583
45. Nowak-Göttl U., Von Kries R., and Gobel U. Neonatal symptomatic thromboembolism in Germany: two year survey. Arch Dis Child Fetal Neonatal Ed 76 (1997) F163-F167
46. Michaels L.A., Gurian M., Hagyi T., et al. Low molecular weight heparin in the treatment of venous and arterial thromboses in the premature infant. Pediatrics 114 (2004) 703-707
47. Massicotte M.P., Dix D., Monagle P., et al. Central venous catheter related thrombosis in children: analysis of the Canadian Registry of Venous Thromboembolic Complications. J Pediatr 133 (1998) 770-776
48. Mocan H., Beattie T.J., Murphy A.V., et al. Renal venous thrombosis in infancy: long-term follow-up. Pediatr Nephrol 5 (1991) 45-49
49. Nuss R., Hays T., and Manco-Johnson M. Efficacy and safety of heparin anticoagulation for neonatal renal vein thrombosis. Am J Pediatr Hematol Oncol 16 (1994) 127-131
50. Keidan I., Lotan D., Gazit G., et al. Early neonatal renal venous thrombosis: long-term outcome. Acta Paediatr 83 (1994) 1225-1227
51. Kuhle S., Massicotte P., Chan A., et al. A case series of 72 neonates with renal vein thrombosis: data from the 1-800-NO-CLOTS Registry. Thromb Haemost 92 (2004) 929-933
52. Kosch A., Kuwertz-Broking E., Heller C., et al. Renal venous thrombosis in neonates: prothrombotic risk factors and long-term follow-up. Blood 104 (2004) 1356-1360
53. deVeber G., Andrew M., Adams C., et al. Cerebral sinovenous thrombosis in children. N Engl J Med 345 (2001) 417-423
54. deVeber G.A., MacGregor D., Curtis R., et al. Neurologic outcome in survivors of childhood arterial ischemic stroke and sinovenous thrombosis. J Child Neurol 15 (2000) 316-324
55. Kenet G., Waldman D., Lubetsky A., et al. Paediatric cerebral sinus vein thrombosis. Thromb Haemost 92 (2004) 713-718
56. De Schryver E.L., Blom I., Braun K.P., et al. Long-term prognosis of cerebral venous sinus thrombosis in childhood. Dev Med Child Neurol 46 (2004) 514-519
57. Gurakan F., Eren M., Kocak N., et al. Extrahepatic portal vein thrombosis in children: etiology and long-term follow-up. J Clin Gastroenterol 38 (2004) 368-372
58. Meissner M.H., Manzo R.A., Bergelin R.O., et al. Deep venous insufficiency: the relationship between lysis and subsequent reflux. J Vasc Surg 18 (1993) 596-605
59. Kahn S.R., Dsmarais S., Ducruet T., et al. Comparison of the Villalta and Ginsberg clinical scales to diagnose the post-thrombotic syndrome: correlation with patient-reported disease burden and venous valvular reflux. J Thromb Haemost 4 (2006) 907-908
60. Revel-Vilk S., Sharathkumar A., Massicotte P., et al. Natural history of arterial and venous thrombosis in children treated with low molecular weight heparin: a longitudinal study by ultrasound. J Thromb Haemost 2 (2004) 42-46
61. Kyrle P.A., Minar E., Hirschl M., et al. High plasma levels of factor VIII and the risk of recurrent venous thromboembolism. N Engl J Med 343 (2000) 457-462
62. Palareti G., Legnani C., Cosmi B., et al. Risk of venous thromboembolism recurrence: high negative predictive value of D-dimer performed after oral anticoagulation is stopped. Thromb Haemost 87 (2002) 7-12
63. Eichinger S., Minar E., Bialonczyk C., et al. D-dimer levels and risk of recurrent venous thromboembolism. JAMA 290 (2003) 1071-1074